Publications

Publications pour l'équipe Oncostat

Titre Publication Type Publication year Auteur
A two-stage drop-the-losers design for time-to-event outcome using a historical control arm journalArticle Rachid Abbas,James Wason,Stefan Michiels,Gwénaël Le Teuff
Incorporation of nested frailties into semiparametric multi-state models journalArticle 2016 Rotolo, F.; Rondeau, V.; Legrand, C.
Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting journalArticle 2018 Imbimbo, M.; Maury, J. M.; Garassino, M.; Girard, N.
Dose finding with longitudinal data: simpler models, richer outcomes journalArticle 2015 Paoletti, X.; Doussau, A.; Ezzalfani, M.; Rizzo, E.; Thiebaut, R.
Risk of Subsequent Leukemia After a Solid Tumor in Childhood: Impact of Bone Marrow Radiation Therapy and Chemotherapy journalArticle 2015 Allodji, R. S.; Schwartz, B.; Veres, C.; Haddy, N.; Rubino, C.; Le Deley, M. C.; Labbé, M.; Diop, F.; Jackson, A.; Dayet, F.; Benabdennebi, A.; Llanas, D.; Vu Bezin, J.; Chavaudra, J.; Lefkopoulos, D.; Deutsch, E.; Oberlin, O.; de Vathaire, F.; Diallo, I.
Pazopanib or placebo in completely resected stage I NSCLC patients: results of the phase II IFCT-0703 trial journalArticle 2017 Besse, B.; Mazières, J.; Ribassin-Majed, L.; Barlesi, F.; Bennouna, J.; Gervais, R.; Moreau, L.; Berard, H.; Debieuvre, D.; Molinier, O.; Moro-Sibilot, D.; Souquet, P. J.; Jacquot, S.; Petit, L.; Lena, H.; Pignon, J. P.; Lacas, B.; Morin, F.; Milleron, B.; Zalcman, G.; Soria, J. C.
An explorative study to assess the association between health-related quality of life and the recommended phase II dose in a phase I trial: idarubicin-loaded beads for chemoembolisation of hepatocellular carcinoma journalArticle 2016 Anota, A.; Boulin, M.; Dabakuyo-Yonli, S.; Hillon, P.; Cercueil, J. P.; Minello, A.; Jouve, J. L.; Paoletti, X.; Bedenne, L.; Guiu, B.; Bonnetain, F.
Clinical outcomes after intensity-modulated proton therapy with concurrent chemotherapy for inoperable non-small cell lung cancer journalArticle 2019 Elhammali, A.; Blanchard, P.; Yoder, A.; Liao, Z.; Zhang, X.; Ronald Zhu, X.; Allen, P. K.; Jeter, M.; Welsh, J.; Nguyen, Q. N.
Optimal cut points for quality of life questionnaire-core 30 (QLQ-C30) scales: utility for clinical trials and updates of prognostic systems in advanced hepatocellular carcinoma journalArticle 2015 Diouf, M.; Bonnetain, F.; Barbare, J. C.; Bouche, O.; Dahan, L.; Paoletti, X.; Filleron, T.
Prospective in silico study of the feasibility and dosimetric advantages of MRI-guided dose adaptation for human papillomavirus positive oropharyngeal cancer patients compared with standard IMRT journalArticle 2018 Mohamed, A. S. R.; Bahig, H.; Aristophanous, M.; Blanchard, P.; Kamal, M.; Ding, Y.; Cardenas, C. E.; Brock, K. K.; Lai, S. Y.; Hutcheson, K. A.; Phan, J.; Wang, J.; Ibbott, G.; Gabr, R. E.; Narayana, P. A.; Garden, A. S.; Rosenthal, D. I.; Gunn, G. B.; Fuller, C. D.; Group, M. D. Anderson MRLinac Development Working
Statistical controversies in clinical research: prognostic gene signatures are not (yet) useful in clinical practice journalArticle 2016 Michiels, S.; Ternes, N.; Rotolo, F.
Percutaneous bone biopsies: comparison between flat-panel cone-beam CT and CT-scan guidance journalArticle 2015 Tselikas, L.; Joskin, J.; Roquet, F.; Farouil, G.; Dreuil, S.; Hakime, A.; Teriitehau, C.; Auperin, A.; de Baere, T.; Deschamps, F.
Is primary tumour resection associated with survival improvement in patients with colorectal cancer and unresectable synchronous metastases? A pooled analysis of individual data from four randomised trials journalArticle 2015 Faron, M.; Pignon, J. P.; Malka, D.; Bourredjem, A.; Douillard, J. Y.; Adenis, A.; Elias, D.; Bouché, O.; Ducreux, M.
Impact of Skin Toxicities Associated with Targeted Cancer Therapies on Body Image: A Prospective Study journalArticle 2016 Charles, C.; Razavi, D.; Bungener, C.; Mateus, C.; Lanoy, E.; Verschoore, M.; Dauchy, S.; Robert, C.
Unilateral or bilateral irradiation in cervical lymph node metastases of unknown primary? A retrospective cohort study journalArticle 2019 Pflumio, C.; Troussier, I.; Sun, X. S.; Salleron, J.; Petit, C.; Caubet, M.; Beddok, A.; Calugaru, V.; Servagi-Vernat, S.; Castelli, J.; Miroir, J.; Krengli, M.; Giraud, P.; Romano, E.; Khalifa, J.; Dore, M.; Blanchard, N.; Coutte, A.; Dupin, C.; Sumodhee, S.; Pointreau, Y.; Patel, S.; Rehailia-Blanchard, A.; Catteau, L.; Bensadoun, R. J.; Tao, Y.; Roth, V.; Geoffrois, L.; Faivre, J. C.; Thariat, J.
Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial journalArticle 2015 Le Tourneau, C.; Delord, J. P.; Goncalves, A.; Gavoille, C.; Dubot, C.; Isambert, N.; Campone, M.; Tredan, O.; Massiani, M. A.; Mauborgne, C.; Armanet, S.; Servant, N.; Bieche, I.; Bernard, V.; Gentien, D.; Jezequel, P.; Attignon, V.; Boyault, S.; Vincent-Salomon, A.; Servois, V.; Sablin, M. P.; Kamal, M.; Paoletti, X.; investigators, Shiva
Empirical extensions of the lasso penalty to reduce the false discovery rate in high-dimensional Cox regression models journalArticle 2016 Ternes, N.; Rotolo, F.; Michiels, S.
Impact of Skin Toxicities Associated with Targeted Cancer Therapies on Body Image: A Prospective Study journalArticle 2016 Charles, C.; Razavi, D.; Bungener, C.; Mateus, C.; Lanoy, E.; Verschoore, M.; Dauchy, S.; Robert, C.
Screening in asymptomatic SDHx mutation carriers: added value of ¹⁸F-FDG PET/CT at initial diagnosis and 1-year follow-up journalArticle 2015 Lepoutre-Lussey, C.; Caramella, C.; Bidault, F.; Déandreis, D.; Berdelou, A.; Al Ghuzlan, A.; Hartl, D.; Borget, I.; Gimenez-Roqueplo, A. P.; Dumont, F.; Deschamps, F.; Nascimento, C.; Lumbroso, J.; Guillaud Bataille, M.; Schlumberger, M.; Baudin, E.; Leboulleux, S.
Burnout among young European oncologists: a call for action journalArticle 2017 Blanchard, P.
Results of a multicenter phase I dose-finding trial of hyperthermic intraperitoneal cisplatin after neoadjuvant chemotherapy and complete cytoreductive surgery and followed by maintenance bevacizumab in initially unresectable ovarian cancer journalArticle 2016 Gouy, S.; Ferron, G.; Glehen, O.; Bayar, A.; Marchal, F.; Pomel, C.; Quenet, F.; Bereder, J. M.; Le Deley, M. C.; Morice, P.
Health state utility and quality of life measures in patients with chronic myeloid leukemia in France journalArticle 2021 Foulon S, Cony-Makhoul P, Guerci-Bresler A, Daban M, Kapso R, Tubert-Bitter P, Bonastre J
Is alpha-fetoprotein decline a prognostic factor of childhood non-seminomatous germ cell tumours? Results of the French TGM95 study journalArticle 2018 Fresneau, B.; Orbach, D.; Faure-Conter, C.; Sudour-Bonnange, H.; Vérité, C.; Gandemer, V.; Pasquet, M.; Fasola, S.; Rome, A.; Raimbault, S.; Martelli, H.; Frappaz, D.; Le Teuff, G.; Patte, C.
Impact of primary para-aortic lymphadenectomy on distant failure in locally advanced cervical cancer patients treated in the era of image-guided adaptive brachytherapy journalArticle 2016 Chargari, C.; Mazeron, R.; Dunant, A.; Gouy, S.; Petit, C.; Maroun, P.; Uzan, C.; Annede, P.; Bentivegna, E.; Balleyguier, C.; Genestie, C.; Pautier, P.; Leary, A.; Lhomme, C.; Deutsch, E.; Morice, P.; Haie-Meder, C.
Impact of early palliative care on overall survival of patients with metastatic upper gastrointestinal cancers treated with first-line chemotherapy: a randomised phase III trial journalArticle 2018 Hutt, E.; Da Silva, A.; Bogart, E.; Le Lay-Diomande, S.; Pannier, D.; Delaine-Clisant, S.; Le Deley, M. C.; Adenis, A.
Intensity Modulated Proton Therapy Versus Intensity Modulated Photon Radiation Therapy for Oropharyngeal Cancer: First Comparative Results of Patient-Reported Outcomes journalArticle 2016 Sio, T. T.; Lin, H. K.; Shi, Q.; Gunn, G. B.; Cleeland, C. S.; Lee, J. J.; Hernandez, M.; Blanchard, P.; Thaker, N. G.; Phan, J.; Rosenthal, D. I.; Garden, A. S.; Morrison, W. H.; Fuller, C. D.; Mendoza, T. R.; Mohan, R.; Wang, X. S.; Frank, S. J.
Design and statistical principles of the SHIVA trial journalArticle 2015 Paoletti, X.; Asselain, B.; Kamal, M.; Servant, N.; Huppe, P.; Bieche, I.; Le Tourneau, C.
The frequency of cancer in France: Most recent data and trends journalArticle 2017 Ribassin-Majed, L.; Le-Teuff, G.; Hill, C.
Lenvatinib for the treatment of radio-iodine refractory thyroid cancer in real-life practice journalArticle 2017 Berdelou, A.; Borget, I.; Godbert, Y.; Nguyen, T.; Garcia, M. E.; Chougnet, C. N.; Ferru, A.; Buffet, C.; Chabre, O.; Huillard, O.; Leboulleux, S.; Schlumberger, M.
Induction chemotherapy followed by radiotherapy for N3 head and neck squamous cell carcinoma journalArticle 2019 Du, C.; Blanchard, P.; Even, C.; Boros, A.; Gorphe, P.; Breuskin, I.; Baste-Rotllan, N.; Nguyen, F.; Ruffier, A.; Bidault, F.; Billard, C.; Janot, F.; Mirghani, H.; Temam, S.; Tao, Y.
Primary cutaneous and subcutaneous Ewing sarcoma journalArticle 2015 Di Giannatale, A.; Frezza, A. M.; Le Deley, M. C.; Marec-Bérard, P.; Benson, C.; Blay, J. Y.; Bui, B.; Judson, I.; Oberlin, O.; Whelan, J.; Gaspar, N.
Smoking impact on HPV driven head and neck cancer's oncological outcomes? journalArticle 2018 Mirghani, H.; Leroy, C.; Chekourry, Y.; Casiraghi, O.; Auperin, A.; Tao, Y.; Nguyen, F.; Caroline, E.; Breuskin, I.; Plana, A. M.; Hartl, D.; Janot, F.; Temam, S.; Gorphe, P.; Blanchard, P.
Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection journalArticle 2015 Tsao, M. S.; Marguet, S.; Le Teuff, G.; Lantuejoul, S.; Shepherd, F. A.; Seymour, L.; Kratzke, R.; Graziano, S. L.; Popper, H. H.; Rosell, R.; Douillard, J. Y.; Le-Chevalier, T.; Pignon, J. P.; Soria, J. C.; Brambilla, E. M.
Mortality from Circulatory System Diseases among French Uranium Miners: A Nested Case-Control Study journalArticle 2015 Drubay, D.; Caer-Lorho, S.; Laroche, P.; Laurier, D.; Rage, E.
Impact of dermatologic adverse events induced by targeted therapies on quality of life journalArticle 2016 Charles, C.; Bungener, C.; Razavi, D.; Mateus, C.; Routier, E.; Lanoy, E.; Verschoore, M.; Robert, C.; Dauchy, S.
Individual patient data network meta-analysis using either restricted mean survival time difference or hazard ratios: is there a difference? A case study on locoregionally advanced nasopharyngeal carcinomas journalArticle 2019 Petit, C.; Blanchard, P.; Pignon, J. P.; Lueza, B.
Precision medicine: lessons learned from the SHIVA trial - Authors' reply journalArticle 2015 Le Tourneau, C.; Belin, L.; Paoletti, X.; Bieche, I.; Kamal, M.
surrosurv: An R package for the evaluation of failure time surrogate endpoints in individual patient data meta-analyses of randomized clinical trials journalArticle 2018 Rotolo, F.; Paoletti, X.; Michiels, S.
Factors associated with success of image-guided tumour biopsies: Results from a prospective molecular triage study (MOSCATO-01) journalArticle 2016 Tacher, V.; Le Deley, M. C.; Hollebecque, A.; Deschamps, F.; Vielh, P.; Hakime, A.; Ileana, E.; Abedi-Ardekani, B.; Charpy, C.; Massard, C.; Rosellini, S.; Gajda, D.; Celebic, A.; Ferte, C.; Ngo-Camus, M.; Gouissem, S.; Koubi-Pick, V.; Andre, F.; Vassal, G.; Deandreis, D.; Lacroix, L.; Soria, J. C.; De Baere, T.
Impact of dermatologic adverse events induced by targeted therapies on quality of life journalArticle 2016 Charles, C.; Bungener, C.; Razavi, D.; Mateus, C.; Routier, E.; Lanoy, E.; Verschoore, M.; Robert, C.; Dauchy, S.